{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:26Z","timestamp":1787003606548,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08580-4","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:42:44Z","timestamp":1752136964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association and predictive value of the triglyceride glucose-weight adjusted waist index for cardiovascular outcomes in patients with type 2 diabetes"],"prefix":"10.1038","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct00000620","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Maojun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-4833","authenticated-orcid":false,"given":"Xinqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"2","key":"8580_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"8580_CR2","doi-asserted-by":"publisher","unstructured":"Dal Canto, E., Ceriello, A., Ryd\u00e9n, L., Ferrini, M., Hansen, T. B., Schnell, O., Standl, E., & Beulens, J. W, Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. European journal of preventive cardiology, 26(2_suppl), 25\u201332. https:\/\/doi.org\/10.1177\/2047487319878371(2019)","DOI":"10.1177\/2047487319878371"},{"issue":"3","key":"8580_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2337\/dci22-0046","volume":"46","author":"W Perng","year":"2023","unstructured":"Perng, W., Conway, R., Mayer-Davis, E. & Dabelea, D. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care 46(3), 490\u2013499. https:\/\/doi.org\/10.2337\/dci22-0046 (2023).","journal-title":"Diabetes Care"},{"key":"8580_CR4","doi-asserted-by":"publisher","unstructured":"Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan B. B., Stein, C., Basit, A., Chan Juliana, C. N., Claude Mbanya, J., Pavkov Meda, E., Ramachandaran, A., Wild Sarah, H., James S., Herman, W. H., Zhang, P., Bommer, C., Kuo, S., Boyko Edward, J., Magliano Dianna, J, Erratum to \"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045\" [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Res Clin Pract, 204, 110945. https:\/\/doi.org\/10.1016\/j.diabres.2023.110945(2023)","DOI":"10.1016\/j.diabres.2023.110945"},{"key":"8580_CR5","doi-asserted-by":"publisher","unstructured":"Yun, J. S., & Ko, S. H, Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism: clinical and experimental, 123, 154838. https:\/\/doi.org\/10.1016\/j.metabol.2021.154838(2021)","DOI":"10.1016\/j.metabol.2021.154838"},{"key":"8580_CR6","doi-asserted-by":"publisher","unstructured":"Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., Djousse, L., Elkind, M. S. V., Ferguson, J. F., Fornage, M., Khan, S. S., Kissela, B. M., Knutson, K. L., Kwan, T. W., Lackland, D. T., Lewis, T. T., American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation, 141(9), e139\u2013e596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757(2020)","DOI":"10.1161\/CIR.0000000000000757"},{"issue":"16","key":"8580_CR7","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jacc.2023.08.015","volume":"82","author":"C Gyldenkerne","year":"2023","unstructured":"Gyldenkerne, C. et al. 10-Year cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus. J. Am. Coll. Cardiol. 82(16), 1583\u20131594. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.015 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9529","key":"8580_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","volume":"368","author":"GL Booth","year":"2006","unstructured":"Booth, G. L., Kapral, M. K., Fung, K. & Tu, J. V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet (London, England) 368(9529), 29\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(06)68967-8 (2006).","journal-title":"Lancet (London, England)"},{"issue":"1","key":"8580_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee, S. H., Park, S. Y. & Choi, C. S. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab. J. 46(1), 15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280 (2022).","journal-title":"Diabetes Metab. J."},{"key":"8580_CR10","doi-asserted-by":"publisher","unstructured":"Hill, M. A., Yang, Y., Zhang, L., Sun, Z., Jia, G., Parrish, A. R., & Sowers, J. R. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism: clinical and experimental, 119, 154766. https:\/\/doi.org\/10.1016\/j.metabol.2021.154766(2021)","DOI":"10.1016\/j.metabol.2021.154766"},{"issue":"2","key":"8580_CR11","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dsx.2019.02.023","volume":"13","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany, M. M., Mart\u00ednez-Rodr\u00edguez, J., Gonz\u00e1lez-Luc\u00e1n, M., Fern\u00e1ndez-Fern\u00e1ndez, C. & Castro-Quintela, E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metabolic Syndr. 13(2), 1449\u20131455. https:\/\/doi.org\/10.1016\/j.dsx.2019.02.023 (2019).","journal-title":"Diabetes Metabolic Syndr."},{"issue":"4","key":"8580_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/joim.13687","volume":"294","author":"JZ Louie","year":"2023","unstructured":"Louie, J. Z., Shiffman, D., McPhaul, M. J. & Melander, O. Insulin resistance probability score and incident cardiovascular disease. J. Intern. Med. 294(4), 531\u2013535. https:\/\/doi.org\/10.1111\/joim.13687 (2023).","journal-title":"J. Intern. Med."},{"issue":"2","key":"8580_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1570161115666171010115119","volume":"17","author":"MA Abdul-Ghani","year":"2019","unstructured":"Abdul-Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N. & Al-Suwaidi, J. Insulin resistance the link between T2DM and CVD: basic mechanisms and clinical implications. Curr. Vasc. Pharmacol. 17(2), 153\u2013163. https:\/\/doi.org\/10.2174\/1570161115666171010115119 (2019).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1","key":"8580_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal, V. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol. 17(1), 122. https:\/\/doi.org\/10.1186\/s12933-018-0762-4 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"8580_CR15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00645.2007","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa, R., Lee, S., Chen, H. & Quon, M. J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am. J. Physiol. Endocrinol. Metabolism https:\/\/doi.org\/10.1152\/ajpendo.00645.2007 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metabolism"},{"issue":"3","key":"8580_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.numecd.2021.11.017","volume":"32","author":"DH Son","year":"2022","unstructured":"Son, D. H., Lee, H. S., Lee, Y. J., Lee, J. H. & Han, J. H. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis 32(3), 596\u2013604. https:\/\/doi.org\/10.1016\/j.numecd.2021.11.017 (2022).","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"8580_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary, D. L. et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride\/glucose index. Diabetes & metabolic syndrome 16(8), 102581. https:\/\/doi.org\/10.1016\/j.dsx.2022.102581 (2022).","journal-title":"Diabetes & metabolic syndrome"},{"issue":"1","key":"8580_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao, L. C., Xu, J. N., Wang, T. T., Hua, F. & Li, J. J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc. Diabetol. 21(1), 68. https:\/\/doi.org\/10.1186\/s12933-022-01511-x (2022).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR19","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S2666-7568(22)00247-1","volume":"4","author":"P Lopez-Jaramillo","year":"2023","unstructured":"Lopez-Jaramillo, P. et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet. Healthy Longevity 4(1), e23\u2013e33. https:\/\/doi.org\/10.1016\/S2666-7568(22)00247-1 (2023).","journal-title":"Lancet. Healthy Longevity"},{"issue":"1","key":"8580_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12933-024-02120-6","volume":"23","author":"Y Yao","year":"2024","unstructured":"Yao, Y. et al. The association between TyG and all-cause\/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999\u20132018. Cardiovasc. Diabetol. 23(1), 43. https:\/\/doi.org\/10.1186\/s12933-024-02120-6 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-025-02604-z","volume":"24","author":"HM He","year":"2025","unstructured":"He, H. M. et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc. Diabetol. 24(1), 69. https:\/\/doi.org\/10.1186\/s12933-025-02604-z (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-024-02261-8","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu, C. & Liang, D. The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged \u2264 65 years with prediabetes or diabetes: a population-based study. Cardiovasc. Diabetol. 23(1), 168. https:\/\/doi.org\/10.1186\/s12933-024-02261-8 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"8580_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11886-024-02129-z","volume":"26","author":"S Koirala","year":"2024","unstructured":"Koirala, S., Sunnaa, M., Bernier, T. & Oktay, A. A. The role of obesity as a cardiac disease risk factor in patients with Type 2 diabetes. Curr. Cardiol. Rep. 26(11), 1309\u20131320. https:\/\/doi.org\/10.1007\/s11886-024-02129-z (2024).","journal-title":"Curr. Cardiol. Rep."},{"key":"8580_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110773","volume":"202","author":"C Boutari","year":"2023","unstructured":"Boutari, C., DeMarsilis, A. & Mantzoros, C. S. Obesity and diabetes. Diabetes Res. Clin. Pract. 202, 110773. https:\/\/doi.org\/10.1016\/j.diabres.2023.110773 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"8580_CR25","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1002\/jcsm.13302","volume":"14","author":"KJ Kim","year":"2023","unstructured":"Kim, K. J., Son, S., Kim, K. J., Kim, S. G. & Kim, N. H. Weight-adjusted waist as an integrated index for fat, muscle and bone health in adults. J. Cachexia. Sarcopenia Muscle 14(5), 2196\u20132203. https:\/\/doi.org\/10.1002\/jcsm.13302 (2023).","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"9","key":"8580_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1006524","volume":"364","author":"HC Gerstein","year":"2011","unstructured":"ACCORD Study Group et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med. 364(9), 818\u2013828. https:\/\/doi.org\/10.1056\/NEJMoa1006524 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"12A","key":"8580_CR27","doi-asserted-by":"publisher","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"ACCORD Study Group et al. Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods. Am. J. Cardiol. 99(12A), 21i\u201333i. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.003 (2007).","journal-title":"Am. J. Cardiol."},{"key":"8580_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076576","volume":"382","author":"V Raleigh","year":"2023","unstructured":"Raleigh, V. & Colombo, F. Cardiovascular disease should be a priority for health systems globally. BMJ (Clinical research ed.) 382, e076576. https:\/\/doi.org\/10.1136\/bmj-2023-076576 (2023).","journal-title":"BMJ (Clinical research ed.)"},{"issue":"6","key":"8580_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40273-023-01258-7","volume":"41","author":"D Abushanab","year":"2023","unstructured":"Abushanab, D. et al. Projecting the health and economic burden of cardiovascular disease among people with type 2 diabetes, 2022\u20132031. Pharmacoeconomics 41(6), 719\u2013732. https:\/\/doi.org\/10.1007\/s40273-023-01258-7 (2023).","journal-title":"Pharmacoeconomics"},{"key":"8580_CR30","doi-asserted-by":"publisher","unstructured":"Marx, N., Federici, M., Sch\u00fctt, K., M\u00fcller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., Espinola-Klein, C., Fauchier, L., Halle, M., Herrington, W. G., Kautzky-Willer, A., Lambrinou, E., Lesiak, M., Lettino, M., McGuire, D. K., Mullens, W., ESC Scientific Document Group, 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. European heart journal, 44(39), 4043\u20134140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192(2023)","DOI":"10.1093\/eurheartj\/ehad192"},{"issue":"1","key":"8580_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s43856-023-00429-z","volume":"4","author":"A Ahmad","year":"2024","unstructured":"Ahmad, A. et al. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis. Commun. Med. 4(1), 11. https:\/\/doi.org\/10.1038\/s43856-023-00429-z (2024).","journal-title":"Commun. Med."},{"issue":"3","key":"8580_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.drudis.2021.11.001","volume":"27","author":"Y Tong","year":"2022","unstructured":"Tong, Y., Xu, S., Huang, L. & Chen, C. Obesity and insulin resistance: Pathophysiology and treatment. Drug Discovery Today 27(3), 822\u2013830. https:\/\/doi.org\/10.1016\/j.drudis.2021.11.001 (2022).","journal-title":"Drug Discovery Today"},{"issue":"11","key":"8580_CR33","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu, H. & Ballantyne, C. M. Metabolic inflammation and insulin resistance in obesity. Circ. Res. 126(11), 1549\u20131564. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315896 (2020).","journal-title":"Circ. Res."},{"issue":"3","key":"8580_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/MS9.0000000000003019","volume":"87","author":"A Alotaibi","year":"2025","unstructured":"Alotaibi, A. et al. Triglyceride-glucose index as a marker in cardiovascular diseases; a bibliometric study and visual analysis. Annals of medicine and surgery 87(3), 1487\u20131505. https:\/\/doi.org\/10.1097\/MS9.0000000000003019 (2025).","journal-title":"Annals of medicine and surgery"},{"key":"8580_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","volume":"131","author":"Y Sun","year":"2025","unstructured":"Sun, Y., Ji, H., Sun, W., An, X. & Lian, F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur. J. Intern. Med. 131, 3\u201314. https:\/\/doi.org\/10.1016\/j.ejim.2024.08.026 (2025).","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"8580_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/cen.15171","volume":"102","author":"Y Luo","year":"2025","unstructured":"Luo, Y. et al. Relationship between body composition and insulin resistance evaluated by the TyG index: a retrospective study among chinese population. Clin. Endocrinol. 102(3), 264\u2013272. https:\/\/doi.org\/10.1111\/cen.15171 (2025).","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"8580_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang, K. et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc. Diabetol. 23(1), 8. https:\/\/doi.org\/10.1186\/s12933-023-02115-9 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12933-024-02290-3","volume":"23","author":"X Xia","year":"2024","unstructured":"Xia, X. et al. Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of Kailuan cohort. Cardiovasc. Diabetol. 23(1), 208. https:\/\/doi.org\/10.1186\/s12933-024-02290-3 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR39","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1038\/s41598-024-63886-z","volume":"14","author":"S Xiao","year":"2024","unstructured":"Xiao, S., Zhang, Q., Yang, H. Y., Tong, J. Y. & Yang, R. Q. The association between triglyceride glucose-body mass index and all-cause and cardiovascular mortality in diabetes patients: a retrospective study from NHANES database. Sci. Rep. 14(1), 13884. https:\/\/doi.org\/10.1038\/s41598-024-63886-z (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"8580_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13098-024-01340-w","volume":"16","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. The association between triglyceride-glucose index and related parameters and risk of cardiovascular disease in American adults under different glucose metabolic states. Diabetology Metabolic Syndr. 16(1), 102. https:\/\/doi.org\/10.1186\/s13098-024-01340-w (2024).","journal-title":"Diabetology Metabolic Syndr."},{"issue":"10","key":"8580_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/obr.12440","volume":"17","author":"AS Antonopoulos","year":"2016","unstructured":"Antonopoulos, A. S., Oikonomou, E. K., Antoniades, C. & Tousoulis, D. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease. Obesity Rev. 17(10), 989\u20131000. https:\/\/doi.org\/10.1111\/obr.12440 (2016).","journal-title":"Obesity Rev."},{"issue":"1","key":"8580_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","volume":"26","author":"S Strulov Shachar","year":"2017","unstructured":"Strulov Shachar, S. & Williams, G. R. The obesity paradox in cancer-moving beyond BMI. Cancer Epidemiol, Biomarkers Prevention 26(1), 13\u201316. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0439 (2017).","journal-title":"Cancer Epidemiol, Biomarkers Prevention"},{"key":"8580_CR43","doi-asserted-by":"publisher","unstructured":"Cornier, M. A., Despr\u00e9s, J. P., Davis, N., Grossniklaus, D. A., Klein, S., Lamarche, B., Lopez-Jimenez, F., Rao, G., St-Onge, M. P., Towfighi, A., Poirier, P., American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, & Council on the Kidney in Cardiovascular Disease, and Stroke Council, Assessing adiposity: a scientific statement from the American Heart Association. Circulation, 124(18), 1996\u20132019. https:\/\/doi.org\/10.1161\/CIR.0b013e318233bc6a(2011)","DOI":"10.1161\/CIR.0b013e318233bc6a"},{"key":"8580_CR44","doi-asserted-by":"publisher","unstructured":"Yusuf, S., Hawken, S., Ounpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., Tanomsup, S., Wangai, P., Jr, Razak, F., Sharma, A. M., Anand, S. S., & INTERHEART Study Investigators, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (London, England), 366 (9497), 1640\u20131649. https:\/\/doi.org\/10.1016\/S0140-6736(05)67663-5(2005)","DOI":"10.1016\/S0140-6736(05)67663-5"},{"issue":"5","key":"8580_CR45","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/MCO.0000000000000485","volume":"21","author":"H Fang","year":"2018","unstructured":"Fang, H., Berg, E., Cheng, X. & Shen, W. How to best assess abdominal obesity. Curr. Opin. Clin. Nutr. Metab. Care 21(5), 360\u2013365. https:\/\/doi.org\/10.1097\/MCO.0000000000000485 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"8580_CR46","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","volume":"8","author":"Y Park","year":"2018","unstructured":"Park, Y., Kim, N. H., Kwon, T. Y. & Kim, S. G. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci. Rep. 8(1), 16753. https:\/\/doi.org\/10.1038\/s41598-018-35073-4 (2018).","journal-title":"Sci. Rep."},{"key":"8580_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.894686","volume":"9","author":"S Cai","year":"2022","unstructured":"Cai, S. et al. Association of the weight-adjusted-waist index with risk of all-cause mortality: A 10-year follow-up study. Front. Nutr. 9, 894686. https:\/\/doi.org\/10.3389\/fnut.2022.894686 (2022).","journal-title":"Front. Nutr."},{"issue":"1","key":"8580_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12933-024-02511-9","volume":"23","author":"C Duan","year":"2024","unstructured":"Duan, C. et al. Associations of baseline and changes in the triglyceride glucose-weight adjusted waist index and cardiovascular disease risk: evidence from middle-aged and older individuals. Cardiovasc. Diabetol. 23(1), 415. https:\/\/doi.org\/10.1186\/s12933-024-02511-9 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"8580_CR49","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1038\/s41598-025-99618-0","volume":"15","author":"G Huo","year":"2025","unstructured":"Huo, G. et al. Association between triglyceride glucose weight adjusted waist index and stroke risk in different glucose metabolism status. Sci. Rep. 15(1), 15813. https:\/\/doi.org\/10.1038\/s41598-025-99618-0 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"8580_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Wu, J., Li, T., Qu, Y. & Wang, Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc. Diabetol. 24(1), 52. https:\/\/doi.org\/10.1186\/s12933-025-02616-9 (2025).","journal-title":"Cardiovasc. Diabetol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:42:45Z","timestamp":1752136965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8580"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08580-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"24573"}}